UCARS 2025 Thursday - Session 3: Myocardial recovery: evidence and implementation

From CAMILA VARGAS February 27, 2025

16 plays 0 comments

Policy

You are responsible for the videos uploaded to the Health Care instance of Media Space, This instance is meant to be a public library of videos. Content should not contain PHI or private information.

Session 3: Myocardial recovery: evidence and implementation (Non-CME)
Chairs: James Long, MD, Integris Health; Stephen McKellar, MD, Intermountain Health

How is progression of disease/HFrEF affecting the cardiac recoverability? Is this the same for all HFrEF therapies? Liviu Klein, UCSF
How to (a) individualize the probability of recovery and (b) guide recommendations for ‘direct transplant’ vs ‘VAD as bridge’. Maya Guglin, MD, Rutgers Robert Wood Johnson
Durability of recovery after VAD weaning: results from VAD WEAN Recovery Registry. Benjamin Sun, MD, Minneapolis Heart Institute
Upgraded recommendations for recovery in the ISHLT guidelines. Michael Tong, MD, Cleveland Clinic
UNOS and INTERMACS evidence of under diagnosis and underutilization of LVAD-mediated recovery. Anelechi Anyanwu, MD, Mount Sinai
Reasons for under diagnosis and underutilization and ways to address them. Palak Shah, MD, INOVA

Discussants Panel: Snehal Patel, MD, Montefiore; Amanda Vest, MD, Cleveland Clinic; Kartik Sundareswaran, PhD, Abbott; Abdallah Kfoury, MD, Intermountain Health; Stavros Drakos, MD/PhD, U of U

Tags: ucarsucars2025mcsheart transplantheart diseaseheart recovery

Date Recorded: February 21, 2025
Health Topics (The Scope Radio): Heart Health
Science Topics: Medical Education
Service Line: Cardiovascular

Looking for more...

UCARS 2025 Thursday - Session 3: Myocardial recovery: evidence and implementation

Policy

You are responsible for the videos uploaded to the Health Care instance of Media Space, This instance is meant to be a public library of videos. Content should not contain PHI or private information.

Related Media